Evidence map›Paper›PMID 33061508›Full record

ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2020

Consumption of Cooked Common Beans or Saponins Could Reduce the Risk of Diabetic Complications.

David Calderón Guzmán, Hugo Juárez Olguín, Quetzalli Veloz Corona, Maribel Ortiz Herrera, Norma Osnaya Brizuela, Gerardo Barragán Mejía

Abstract readReview
In one paragraph

Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Exploring the bioactive-based therapeutic and culinary potential ofJournal of food science and technology · 2025
    Review
  2. Post COVID-19 Vertigo in a Patient with Hypothyroidism: A Case Report.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David Calderón GuzmánLaboratory of Neurosciences, Instituto Nacional de Pediatría (INP), Mexico City, Mexico.
Hugo Juárez OlguínLaboratory of Pharmacology, INP, Mexico City, Mexico.ORCID 0000-0002-1405-1728
Quetzalli Veloz CoronaLaboratory of Pharmacology, INP, Mexico City, Mexico.
Maribel Ortiz HerreraLaboratory of Experimental Bacteriology, INP, Mexico City, Mexico.
Norma Osnaya BrizuelaLaboratory of Neurosciences, Instituto Nacional de Pediatría (INP), Mexico City, Mexico.
Gerardo Barragán MejíaLaboratory of Experimental Bacteriology, INP, Mexico City, Mexico.ORCID 0000-0002-7670-0711

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several risks for diseases, such as atherosclerosis, renal diseases, and diabetes, have inextricably been linked with obesity. Nowadays, this health-risk-laden disease is being managed with assorted types of drugs, some of which guarantee modest benefits. The chronic inflammatory effect of obesity has a negative effect in insulin signaling, a situation attributable to insulin resistance that culminates in high blood sugar inputs seen in diseases such as type 2 diabetes and metabolic syndrome. Food such as beans with different bioactive compounds could reduce the risk of diabetic complications. Demand for bean products is growing because of its robust contents of several health-promoting components, eg, saponins. Saponins are characterized by containing lower glucose and cholesterol levels and have been doted with antioxidant activities, as well as anti-inflammatory and anti-diabetic effects. In this writing, the attributes of saponins in providing substantial health and nutritional benefits in humans, as well as in improving and ameliorating diabetic complications, were reviewed.

Indexed as

beansdiabetessaponins

Identifiers

PMID33061508
PMCPMC7537848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.